What happened
Aberdeen University researchers, in collaboration with Kheiron Medical Technologies, demonstrated that the Mia AI tool increased breast cancer detection by 10.4% in mammogram screenings. The study evaluated the AI software across 10,889 women in NHS Grampian, also reducing healthcare worker workload by over 30% and patient notification times from 14 to three days. This comprehensive evaluation, the first of its kind in the UK, identified more invasive and high-grade cancers, with a larger UK-wide trial now planned.
Why it matters
Earlier cancer detection directly improves patient outcomes, shifting treatment to less invasive and more successful stages. For healthcare architects and procurement teams, this validated AI application presents a clear mechanism to reduce operational costs through decreased radiologist workload and fewer unnecessary recalls, while simultaneously enhancing diagnostic accuracy. The proven ability of AI to identify subtle anomalies human eyes might miss establishes a new benchmark for diagnostic efficiency and patient care, particularly as healthcare systems face radiologist shortages.
Subscribe for Weekly Updates
Stay ahead with our weekly AI and tech briefings, delivered every Tuesday.
